MedTrace Logo

Metadherin mRNA Expression in Bladder Cancer

NCT04286672 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2020-09-29

No results posted yet for this study

Summary

The study aims to study alterations of MTDH gene expression in the serum of bladder cancer patients compared to control group to evaluate its role as a marker for diagnosis.

,to compare the diagnostic accuracy of MTDH with the previously used marker Bladder Cancer-Specific Antigen-1 (BLCA-1 in the serum of bladder cancer patients .

and to study correlation between expression of the metadherin gene and serum level of BLCA-1, and clinical and histopathological staging in patients with bladder cancer

Conditions

Interventions

DIAGNOSTIC_TEST

Metadherin

study alterations of MTDH gene expression in the serum of bladder cancer patients

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Lubna M. Tag El-Din, Doctorate · Lubna Mohamed Tag El-Din

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-31
Primary Completion
2021-01-31
Completion
2022-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04286672 on ClinicalTrials.gov